Dr Reddys Laboratories (RDY) Total Debt (QoQ) (2009 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Total Debt (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.74% |
| Mar 31, 2026 | 15.77% |
| Dec 31, 2025 | 31.51% |
| Sep 30, 2025 | 19.14% |
| Jun 30, 2025 | -4.18% |
| Mar 31, 2025 | -10.44% |
| Dec 31, 2024 | 4.64% |
| Sep 30, 2024 | 60.55% |
| Jun 30, 2024 | 56.38% |
| Mar 31, 2024 | 1.45% |
| Dec 31, 2023 | 38.79% |
| Sep 30, 2023 | 4.35% |
| Jun 30, 2023 | 45.46% |
| Mar 31, 2023 | -54.08% |
| Dec 31, 2022 | 5.89% |
| Sep 30, 2022 | -40.99% |
| Jun 30, 2022 | -15.83% |
| Mar 31, 2022 | 15.62% |
| Dec 31, 2021 | -8.93% |
| Sep 30, 2021 | -9.75% |